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We describe the epidemiology of a pertussis outbreak in 
Japan in 2010–2011 and Bordetella holmesii transmission. 
Six patients were infected; 4 patients were students and a 
teacher at the same junior high school. Epidemiologic links 
were found between 5 patients. B. holmesii may have been 
transmitted from person to person.
B
ordetella holmesii, a small gram-negative coccoid 
bacillus that was ﬁ   rst reported in 1995 (1), was 
originally identiﬁ   ed as a member of the Centers for 
Disease Control and Prevention nonoxidizer group 2. The 
organism is associated with bacteremia, endocarditis, and 
pneumonia, usually in patients with underlying disorders 
such as asplenia or sickle cell anemia, and has been 
isolated from blood and sputum samples (1–5). B. holmesii 
may also be responsible for causing symptoms similar to 
those of pertussis (whooping cough) in otherwise healthy 
patients (6). Large surveillance studies in the United States 
and Canada have shown that the organism was detected in 
nasopharyngeal swab (NPS) specimens of patients with 
pertussis-like symptoms (7,8). Although humans may 
be infected with B. holmesii, transmission of B. holmesii 
between humans has not yet been fully elucidated.
Pertussis is a highly contagious disease caused by 
the bacterium B. pertussis. The organism is known to be 
transmitted from person to person by airborne droplets 
(9). During a recent pertussis outbreak, we conducted a 
laboratory-based active surveillance study and detected 
76 suspected cases of pertussis. Among these cases, we 
identiﬁ  ed not only B. pertussis infection but also B. holmesii 
infection. The purpose of this study was to describe the 
epidemiology of the pertussis outbreak and to determine 
the epidemiologic relatedness of B. holmesii transmission.
The Study
During 2010–2011, a pertussis outbreak occurred in 
a suburban town (town A) in Nobeoka City in Miyazaki 
Prefecture, Japan. Town A has a population of 4,227 
persons and an elementary school and junior high school. 
The ﬁ  rst pertussis case (in a 17-year-old boy) was reported 
in September 2010. From that time, we conducted a 
laboratory-based active surveillance study in the area until 
April 2011, in cooperation with clinics, hospitals, and local 
health departments. Pertussis-suspected cases were deﬁ  ned 
as an illness with cough lasting for >2 weeks, and pertussis-
conﬁ  rmed cases were deﬁ  ned as the presence of 1 of the 
following laboratory ﬁ   ndings: a culture-positive result 
for Bordetella species from NPS specimens, or a positive 
result for molecular testing for Bordetella species.
For molecular testing, we conducted conventional 
PCR speciﬁ  c for insertion sequence IS481, which is known 
to detect B. pertussis and B. holmesii, and B. pertussis–
speciﬁ  c loop-mediated isothermal ampliﬁ  cation assays (10–
12). To further conﬁ  rm B. holmesii infection, B. holmesii–
speciﬁ  c real-time PCR speciﬁ  c for the recA gene was also 
performed as described (8). For conﬁ   rmed cases of B. 
holmesii infection, we collected the general information for 
patients (clinical symptoms, treatment, contact information, 
and outcome) by face-to-face interview or questionnaire.
During the pertussis outbreak, we identiﬁ  ed  76 
suspected pertussis cases. Among these suspected 
cases, 35 cases were conﬁ   rmed by laboratory testing 
and involved persons 2–63 years of age (median age 13 
years); 1 case occurred in a 2-year-old child, 14 in 6- to 
12-year-old children, 14 in 13–15-year-old children, and 6 
in persons >16 years of age. Despite pertussis vaccination 
rates in childhood of 82.3%−92.6%, most (80%) patients 
were students 6–12 and 13–15 years of age. Among the 
35 conﬁ  rmed case-patients, 29 and 6 patients showed B. 
pertussis and B. holmesii infection, respectively. Conﬁ  rmed 
cases of B. holmesii infection were observed within the last 
half of the epidemic curve, i.e., weeks 1–12 of 2011 (Figure 
1). There were no cases of co-infection with B. pertussis 
and B. holmesii.
All NPS specimens from patients with B. holmesii 
infection showed a negative result for the B. pertussis loop-
mediated isothermal ampliﬁ   cation, but showed positive 
results in the IS481 PCR and B. holmesii recA real-time 
PCR (Table 1). B. holmesii-like organisms were obtained 
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from 5 patients, and these were identiﬁ  ed as B. holmesii 
by  recA gene sequencing. Patient 6 had been treated 
with antimicrobial drugs before the culture test, which 
probably resulted in a culture-negative test result in this 
patient. Real-time PCR conﬁ  rmed that patient 6 had a low 
B. holmesii DNA load (threshold cycle 36.6) in her NPS 
specimen. All patients experienced paroxysms of coughing 
without posttussive vomiting, especially at night, and 3 also 
experienced a whoop (Table 2). Five of 6 patients had a 
persistent cough lasting >2 weeks. No patients experienced 
any complications, and they were treated mainly with 
azithromycin, resulting in complete recovery. None of the 
patients were immunocompromised.
Our surveillance study showed epidemiologic linkage 
between 5 patients (patients 2–6), but not for patient 1 
(Figure 2). Patient 1, a student in high school A, had the 
ﬁ  rst case of B. holmesii infection (probable index case). 
He lived in a dormitory outside Nobeoka City. However, 
his family home was in town A in Nobeoka City, and he 
returned to his home at the end of 2010 and remained there 
in 2011. Patients 2, 3, and 4 were students at the same junior 
high school (B) in town A and were close friends. Patient 
5 was a teacher at junior high school B and was in charge 
of patient 4. Patient 6 was a medical practitioner at clinic 
C, which is 1 of 2 clinics in town A. Patients 1–5 visited 
clinic C in early January, late February, late February, early 
March, and late March, 2011, respectively. The duration 
of illness in patient 1 did not overlap with that of the other 
patients, whereas that of patients 2–6 clearly overlapped.
Conclusions
In the past 16 years, ≈70 B. holmesii clinical strains 
have been isolated from human patients in several countries, 
mainly the United States. All reported cases of B. holmesii 
infection have been sporadic occurrences. Thus, the 
reservoir of B. holmesii is currently unknown. Moreover, 
whether B. holmesii is transmitted between humans is not 
known. In this report, we have demonstrated that 5 patients 
infected with B. holmesii showed epidemiologic linkage. 
In particular, the fact that 4 of these patients attended the 
same junior high school suggests that B. holmesii may be 
transmitted from person to person.
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 7, July 2012  1167
Figure 1. Epidemic curve of a pertussis 
outbreak, September 2010–April 2011, 
Japan. A) Suspected cases of pertussis. B) 
Laboratory-conﬁ   rmed cases of Bordetella 
pertussis and B. holmesii infection. *As of 
September 20–26, 2010.
Table 1. Characteristics of Bordetella holmesii infection in 6 patients during pertussis outbreak, Japan, September 2010–April 2011*
Patient no.  Age, y/sex  Duration of cough, d† 
B. holmesii test results
recA real-time PCR (Ct)‡ Culture§ 
1 17/M  5  +  (28.7)  + 
2 15/F  4  +  (23.4)  + 
3 15/F  >14  +  (21.6)  + 
4 14/F  8  +  (25.1)  + 
5 40/M  8  +  (27.0)  + 
6 45/F  15  +  (36.6)  –
*All patients had negative results for B. pertussis loop-mediated isothermal amplification and positive results for IS481 PCR. Ct, cycle threshold; –, 
negative; +, positive. 
†At time of specimen collection. 
‡Detection limit was a Ct value of 38.7, corresponding to 100 fg of DNA of B. holmesii ATCC51541. 
§All strains were isolated from nasopharyngeal swab specimens. A previous report suggested that B. holmesii and B. 
pertussis may co-circulate in young adults (7). However, 
the relationship between pertussis epidemics and B. 
holmesii infection is not fully understood. Our active 
surveillance study showed that B. holmesii infection spread 
concurrently with the B. pertussis epidemic, but that there 
was no co-infection of B. holmesii and B. pertussis. Our 
observations demonstrate that accurate diagnosis is needed 
to discriminate between B. holmesii and B. pertussis 
infections during a pertussis outbreak because symptoms 
associated with these 2 diseases are similar.
In 2012, a patient with B. holmesii infectious 
pericarditis was reported in Japan (13). This is probably the 
ﬁ  rst case report of B. holmesii infection in Asia. Previous 
surveillance studies conducted in the United States and 
Canada have shown low rates (0.1%–0.3%) of B. holmesii 
infection in patients with cough (7,8). However, in a 
recent study, B. holmesii DNA was detected in 20% of 
NPS specimens collected from patients in France who 
had been given a diagnosis of B. pertussis infection (14). 
These surveillance data indicate that B. holmesii infection 
is present in adolescents and adults, and that the organism 
is associated with pertussis-like symptoms. However, other 
causes of viral or bacterial respiratory infection cannot be 
excluded. Because of lack of speciﬁ  c diagnostic tools to 
detect bordetellae, B. holmesii infection may have been 
underestimated. Accurate diagnosis and further studies 
are required to fully elucidate the nature of B. holmesii 
infection.
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etymologia etymologia
Rabies
[ra′bēz]
From the Latin rabere (to rage), which may have roots in the Sanskrit rabhas (to do violence). Acute progres-
sive fatal encephalomyelitis caused by neurotropic viruses in the genus Lyssavirus—from the Greek lyssa (frenzy or 
madness). In Greek mythology, Lyssa was the goddess of rage, fury, and rabies, known for driving mad the dogs of 
the hunter Acteon and causing them to kill their master.
Democritus (460–370) described rabies, and Hippocrates is believed to refer to the disease when he said that 
“persons in a frenzy drink very little, are disturbed and frightened, tremble at the least noise, or are seized with 
convulsions.” According to Aristotle, “Dogs suff  er from the madness. Th   is causes them to become irritable and 
all animals they bite to become diseased.” Th   e disease in humans was characterized by hydrophobia, in which the 
sick person was simultaneously tormented with thirst and fear of water. Th   e Roman writer Cardanus described the 
saliva from a rabid dog as a virus, the Latin word for poison.
Canine rabies has been eliminated in the continental United States. However, dog bites remain a concern for 
travelers to areas where the disease is enzootic.
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